Consensus statement of the Society of Critical Care Medicine's Ethics Committee regarding futile and other possibly inadvisable treatments

Critical Care Medicine

Abstract

Society must always face the reality of limited medical resources and must find mechanisms for distributing these resources fairly and efficiently. One recent approach for distributing limited medical resources has been the development of policies that limit the availability of futile treatments. The objectives of this consensus statement are as follows: a) to define futility and thereby enable a clear discussion of the issues; and b) to identify principles and procedures for resolving cases in which life-sustaining treatment may be futile or inadvisable. A literature review, synthesis, and committee discussion. Treatments should be defined as futile only when they will not accomplish their intended goal. Treatments that are extremely unlikely to be beneficial, are extremely costly, or are of uncertain benefit may be considered inappropriate and hence inadvisable, but should not be labeled futile. Futile treatments constitute a small fraction of medical care. Thus, employing the concept of futile care in decision-making will not primarily contribute to a reduction in resource use. Nonetheless, communities have a legitimate interest in allocating medical resources by limiting inadvisable treatments. Communities should seek to do...Continue Reading

References

Jun 15, 1990·Annals of Internal Medicine·L J SchneidermanA R Jonsen
Nov 1, 1988·Critical Care Medicine·M M PollackP R Getson
Aug 1, 1994·Journal of the American Geriatrics Society·J J Fins
Jun 1, 1994·Intensive & Critical Care Nursing : the Official Journal of the British Association of Critical Care Nurses·A J Leathart
Aug 1, 1994·Journal of the American Geriatrics Society·D Callahan
Aug 1, 1994·Journal of the American Geriatrics Society·J D Lantos
Aug 1, 1994·Journal of the American Geriatrics Society·H Brody
Aug 1, 1994·Journal of the American Geriatrics Society·L J Schneiderman
Aug 1, 1994·Journal of the American Geriatrics Society·D J Murphy
Aug 1, 1994·Journal of the American Geriatrics Society·R E Cranford
May 26, 1994·The New England Journal of Medicine·G J Annas
Nov 24, 1993·JAMA : the Journal of the American Medical Association·S LemeshowJ Rapoport
Dec 22, 1993·JAMA : the Journal of the American Medical Association·J R Le GallF Saulnier
Jan 1, 1993·Cambridge Quarterly of Healthcare Ethics : CQ : the International Journal of Healthcare Ethics Committees·W Knaus
Jan 8, 1996·Archives of Internal Medicine·A HalevyB A Brody
Aug 21, 1996·JAMA : the Journal of the American Medical Association·A Halevy, B A Brody

❮ Previous
Next ❯

Citations

Feb 17, 2000·Clinical Cardiology·W D Doty, R M Walker
Mar 11, 2004·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Deborah CookDaren Heyland
Mar 22, 2008·Intensive Care Medicine·Christian J Wiedermann, Christiane Druml
Aug 17, 2011·Intensive Care Medicine·Robin CremerUNKNOWN GFRUP's study group on forgoing treatments
Jul 21, 2006·Wiener klinische Wochenschrift·Andreas Valentin
Sep 25, 2010·Wiener medizinische Wochenschrift·Christian J WiedermannAndreas Valentin
Apr 28, 2006·HEC Forum : an Interdisciplinary Journal on Hospitals' Ethical and Legal Issues·Lisa Anderson-ShawJohn J Lantos
Jul 3, 2007·HEC Forum : an Interdisciplinary Journal on Hospitals' Ethical and Legal Issues·Susan B Rubin
Jun 19, 2001·Primary Care·P Rousseau
Apr 30, 2003·Social Science & Medicine·Sharon R Kaufman
Jun 1, 2002·Critical Care Nursing Clinics of North America·Ferne C Kyba
Mar 3, 2001·Critical Care Medicine·J M Luce, A Alpers
May 30, 2001·Critical Care Medicine·M D FettersM Danis
Jun 1, 2001·Critical Care Medicine·J M Luce
Aug 7, 2002·Critical Care Medicine·Jack E Zimmerman
Feb 11, 2003·Critical Care Medicine·Neal H Cohen
Dec 12, 2003·Critical Care Medicine·Martin A Strosberg, Daniel Teres
Feb 6, 2004·Critical Care Medicine·Thomas A BuckleyFlorence H Y Yap
Feb 16, 2006·Critical Care Medicine·Margaret M Parker
Mar 1, 2006·Critical Care Medicine·Tasnim SinuffStephen D Walter
Jan 24, 2007·Critical Care Medicine·Dan R Thompson
Jan 24, 2007·Critical Care Medicine·Nicholas S Ward, Mitchell M Levy
Nov 18, 2005·Current Opinion in Critical Care·Douglas B White, J Randall Curtis
Apr 24, 2008·Critical Care Medicine·Robert D TruogUNKNOWN American Academy of Critical Care Medicine
Apr 23, 2009·Critical Care Medicine·Colin R CookeUNKNOWN National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome Network
Nov 15, 2011·Critical Care Medicine·Shannon S CarsonUNKNOWN ProVent Investigators
Jun 30, 2012·The Journal of Trauma and Acute Care Surgery·Ross J FleischmanCraig D Newgard
May 28, 2005·Nursing in Critical Care·Michelle Ryder-Lewis
Aug 1, 2006·Journal of Medical Ethics·K L Rodriguez, A J Young
Dec 31, 1997·American Journal of Respiratory and Critical Care Medicine·J M Luce
Feb 17, 2009·Philosophy, Ethics, and Humanities in Medicine : PEHM·Robert C McDermid, Sean M Bagshaw
Nov 1, 2000·Critical Care : the Official Journal of the Critical Care Forum·N MiguelF Gahete
Aug 18, 2004·Critical Care : the Official Journal of the Critical Care Forum·Scott GunnJean-Louis Vincent
Jul 1, 2008·Journal of Oncology Practice·Mary S McCabe, Courtney Storm
Nov 6, 2001·Journal of Personality Assessment·C A Claassen, R Lovitt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.